خانه › سرطان مثانه › نیویورک › New York City
آزمایش‌های بالینی سرطان مثانه در New York City، NY
35 مطالعه برای سرطان مثانه در مراکز New York City (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
در حال جذب شرکت‌کنندهمرحله 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
در حال جذب شرکت‌کنندهمرحله 3
- Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- و 2 مورد دیگر
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
در حال جذب شرکت‌کنندهمرحله 1/2
- Memorial Sloan Kettering Cancer Center ( Site 5031), New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ایپذیرش داوطلبان سالم
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 2
- Memorial Sloan Kettering Hospital, New York
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
در حال جذب شرکت‌کنندهمرحله 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
در حال جذب شرکت‌کنندهمرحله 2
- NYP/Weill Cornell Medical Center, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
در حال جذب شرکت‌کنندهمرحله 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- Icahn School of Medicine at Mount Sinai, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Columbia University Irving Medical Center, New York
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street, New York
- Icahn School of Medicine at Mount Sinai, New York
- و 3 مورد دیگر
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
در حال جذب شرکت‌کنندهمرحله 3
- Memorial Sloan Kettering Cancer Center ( Site 0832), New York
A Study of Surgical Techniques During Cystectomy
در حال جذب شرکت‌کنندهمرحله 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
در حال جذب شرکت‌کنندهمرحله 3
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
در حال جذب شرکت‌کنندهمرحله 1
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
در حال جذب شرکت‌کنندهمرحله 2
- Integrated Medical Professionals, PLLC (Solaris), New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
در حال جذب شرکت‌کننده
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
در حال جذب شرکت‌کنندهمرحله 2
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
در حال جذب شرکت‌کنندهمرحله 1
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- و 2 مورد دیگر
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
در حال جذب شرکت‌کنندهمرحله 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Side Effects and Resource Navigation Program for People With Cancer
در حال جذب شرکت‌کننده
- City College of New York (Data Collection AND Specimen Analysis), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
در حال جذب شرکت‌کنندهمرحله 2/3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
در حال جذب شرکت‌کنندهمرحله 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
در حال جذب شرکت‌کنندهمرحله 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Icahn School of Medicine at Mount Sinai, New York
- Evelyn H. Lauder Breast and Imaging Centre (BAIC), New York
- و 2 مورد دیگر
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
در حال جذب شرکت‌کننده
- Integrated Medical Professionals, New York
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
در حال جذب شرکت‌کنندهمرحله 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Blue Light Cystoscopy With Cysview® Registry
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- NYU Langone's Perlmutter Cancer Center, New York
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
در حال جذب شرکت‌کننده
- Mount Sinai Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Massive Bio SYNERGY-AI site, New York
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
در حال جذب شرکت‌کنندهمرحله 2
- Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York
آزمایش‌های سرطان مثانه در سایر شهرها
- Nashville, TN31 مطالعه
- Houston, TX31 مطالعه
- Dallas, TX27 مطالعه
- Washington, DC26 مطالعه
- Boston, MA26 مطالعه
- Baltimore, MD24 مطالعه
- Los Angeles, CA24 مطالعه
- St. Louis, MO22 مطالعه
- Seattle, WA21 مطالعه
- Philadelphia, PA21 مطالعه
- Edison, NJ21 مطالعه
- Chicago, IL21 مطالعه
سایر مطالعات در New York City
- سرطان پستان136 مطالعه
- سرطان ریه غیرسلول کوچک121 مطالعه
- سرطان (همه انواع)109 مطالعه
- سرطان پروستات103 مطالعه
- سرطان متاستاتیک93 مطالعه
- سرطان کولورکتال78 مطالعه
- سرطان تخمدان69 مطالعه
- سرطان ریه60 مطالعه
- میلوم متعدد60 مطالعه
- سرطان لوزالمعده60 مطالعه
- سرطان آندومتر52 مطالعه
- لوکمیه حاد میلویید51 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 6 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.